Clinical Trial Update: A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes [Phase 1]

View source ↗

Summary

This Phase 1 study assessed the safety, pharmacokinetics, and antiviral activity of ABI-5366 in healthy participants and HSV-2 seropositive individuals with rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Herpes

Drugs mentioned

• ABI-5366

Snippet

Sponsor: Assembly Biosciences | Conditions: Recurrent Genital Herpes Simplex Type 2 | Phase 1 | Status: COMPLETED